We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONON:NYSEOn Holding AG Analysis

Data as of 2026-05-23 - not real-time

$39.81

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

On Holding AG (ONON) trades at $39.81, comfortably above its 20‑day (36.12) and 50‑day (35.92) SMAs but still below the 200‑day SMA of 42.22, indicating short‑term momentum with a longer‑term correction in play. Technical indicators are mixed: the RSI sits at 65.8 (near‑overbought but not yet critical), while the MACD shows a bullish divergence (line 0.69 vs signal 0.14) and a positive histogram, supporting a cautious buy bias. Volume is increasing, and the stock is approaching its resistance at $40.15, suggesting a potential breakout if buying pressure sustains.
Fundamentally, ONON delivers strong top‑line growth (14.5% YoY revenue expansion) and robust margins (gross 63.9%, operating 14.1%). However, valuation is stretched: a trailing PE of 41.9 versus a forward PE of 18.3, and a DCF fair value of $18.56—less than half the current price—imply an overvalued profile with a 33.6% implied downside. The balance sheet shows $1.02 bn cash against $0.54 bn debt (debt‑to‑equity 30.6), but the high beta (1.59) and 30‑day volatility (35%) flag significant market risk. Analyst consensus remains a “Buy,” yet the price premium and sector weakness (Zacks Retail – Apparel & Shoes down 9.2%) temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD with positive histogram
  • Price nearing short‑term resistance at $40.15
  • High beta and volatility suggesting price swings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and healthy margins
  • Valuation gap between market price and DCF fair value
  • Sector underperformance and elevated beta

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Brand momentum in performance footwear
  • Sustainable cash generation versus moderate debt
  • Persistently high valuation multiples

Key Metrics & Analysis

Financial Health

Revenue Growth14.50%
Profit Margin8.02%
P/E Ratio41.9
ROE15.50%
ROA9.68%
Debt/Equity30.59
P/B Ratio5.9
Op. Cash Flow$400.7M
Free Cash Flow$240.1M

Technical Analysis

TrendNeutral
RSI65.8
Support$31.62
Resistance$40.15
MA 20$36.12
MA 50$35.92
MA 200$42.22
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$18.57
Target Price$53.18
Upside/Downside33.58%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.59
Volatility35.03%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.